These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
23. Vgamma9Vdelta2 T cell-mediated non-cytolytic antiviral mechanisms and their potential for cell-based therapy. Poccia F; Agrati C; Martini F; Mejia G; Wallace M; Malkovsky M Immunol Lett; 2005 Aug; 100(1):14-20. PubMed ID: 16115692 [TBL] [Abstract][Full Text] [Related]
24. Exhaustion and Inflation at Antipodes of T Cell Responses to Chronic Virus Infection. Cicin-Sain L; Arens R Trends Microbiol; 2018 Jun; 26(6):498-509. PubMed ID: 29249600 [TBL] [Abstract][Full Text] [Related]
25. Pleiotropic Roles of Type 1 Interferons in Antiviral Immune Responses. Teijaro JR Adv Immunol; 2016; 132():135-158. PubMed ID: 27769506 [TBL] [Abstract][Full Text] [Related]
26. NK cells inhibit humoral immunity by reducing the abundance of CD4+ T follicular helper cells during a chronic virus infection. Cook KD; Kline HC; Whitmire JK J Leukoc Biol; 2015 Aug; 98(2):153-62. PubMed ID: 25986014 [TBL] [Abstract][Full Text] [Related]
27. Travels along the viral-immunobiology highway. Oldstone MB Immunol Rev; 2002 Jul; 185():54-68. PubMed ID: 12190922 [TBL] [Abstract][Full Text] [Related]
28. In vivo imaging of adaptive immune responses to viruses. De Giovanni M; Iannacone M Curr Opin Virol; 2018 Feb; 28():102-107. PubMed ID: 29287222 [TBL] [Abstract][Full Text] [Related]
29. The "ABC" of Virus-Specific T Cell Immunity in Solid Organ Transplantation. Sester M; Leboeuf C; Schmidt T; Hirsch HH Am J Transplant; 2016 Jun; 16(6):1697-706. PubMed ID: 26699950 [TBL] [Abstract][Full Text] [Related]
30. IL-10: achieving balance during persistent viral infection. Ng CT; Oldstone MB Curr Top Microbiol Immunol; 2014; 380():129-44. PubMed ID: 25004816 [TBL] [Abstract][Full Text] [Related]
31. T-cell therapy for chronic viral hepatitis. Bertoletti A; Tan AT; Koh S Cytotherapy; 2017 Nov; 19(11):1317-1324. PubMed ID: 28847469 [TBL] [Abstract][Full Text] [Related]
32. Immune-surveillance through exhausted effector T-cells. Zehn D; Utzschneider DT; Thimme R Curr Opin Virol; 2016 Feb; 16():49-54. PubMed ID: 26826950 [TBL] [Abstract][Full Text] [Related]
33. Functional signatures of protective antiviral T-cell immunity in human virus infections. Harari A; Dutoit V; Cellerai C; Bart PA; Du Pasquier RA; Pantaleo G Immunol Rev; 2006 Jun; 211():236-54. PubMed ID: 16824132 [TBL] [Abstract][Full Text] [Related]
34. Antigen-presenting particle technology using inactivated surface-engineered viruses: induction of immune responses against infectious agents. Mosca JD; Chang YN; Williams G Retrovirology; 2007 May; 4():32. PubMed ID: 17504532 [TBL] [Abstract][Full Text] [Related]
35. Viral strategies for evading antiviral cellular immune responses of the host. Iannello A; Debbeche O; Martin E; Attalah LH; Samarani S; Ahmad A J Leukoc Biol; 2006 Jan; 79(1):16-35. PubMed ID: 16204622 [TBL] [Abstract][Full Text] [Related]
36. The role of T-cell-mediated mechanisms in virus infections of the nervous system. Dörries R Curr Top Microbiol Immunol; 2001; 253():219-45. PubMed ID: 11417137 [TBL] [Abstract][Full Text] [Related]
37. mTOR Promotes Antiviral Humoral Immunity by Differentially Regulating CD4 Helper T Cell and B Cell Responses. Ye L; Lee J; Xu L; Mohammed AU; Li W; Hale JS; Tan WG; Wu T; Davis CW; Ahmed R; Araki K J Virol; 2017 Feb; 91(4):. PubMed ID: 27974559 [TBL] [Abstract][Full Text] [Related]
38. Accelerated viral dynamics in bat cell lines, with implications for zoonotic emergence. Brook CE; Boots M; Chandran K; Dobson AP; Drosten C; Graham AL; Grenfell BT; Müller MA; Ng M; Wang LF; van Leeuwen A Elife; 2020 Feb; 9():. PubMed ID: 32011232 [TBL] [Abstract][Full Text] [Related]